Biostax Corp.
BTAX
$0.01
$0.00111.11%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.04M | 1.00M | 957.50K | 944.20K | 1.13M |
| Depreciation & Amortization | 27.20K | 40.60K | 54.00K | 40.20K | 26.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.21M | 1.35M | 1.48M | 1.46M | 1.53M |
| Operating Income | -1.21M | -1.35M | -1.48M | -1.46M | -1.53M |
| Income Before Tax | -2.21M | -2.28M | -2.36M | -1.59M | -3.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.21 | -2.28 | -2.36 | -1.59 | -3.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.21M | -2.28M | -2.36M | -1.59M | -3.69M |
| EBIT | -1.21M | -1.35M | -1.48M | -1.46M | -1.53M |
| EBITDA | -1.16M | -1.29M | -1.43M | -1.15M | -812.50K |
| EPS Basic | -0.03 | -0.03 | -0.03 | -0.02 | -0.06 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.03 | -0.03 | -0.03 | -0.02 | -0.06 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 334.30M | 333.89M | 333.42M | 333.00M | 309.85M |
| Average Diluted Shares Outstanding | 336.37M | 335.96M | 333.42M | 333.00M | 309.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
